ENTO
Entero Therapeutics
ENTO
ENTO
9 hedge funds and large institutions have $47.6K invested in Entero Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$6.31K | |
2 | +$5.09K | |
3 | +$5K | |
4 |
Citadel Advisors
Miami,
Florida
|
+$4.97K |
5 |
Bank of America
Charlotte,
North Carolina
|
+$1 |
Top Sellers
1 | -$15K | |
2 | -$13K | |
3 | -$4.8K | |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2 |